首页> 外文期刊>Indian Journal of Pharmaceutical Education & Research >Formulation and Evaluation of Mucoadhesive Buccal Films of Esomeprazoie Magnesium Trihydrate
【24h】

Formulation and Evaluation of Mucoadhesive Buccal Films of Esomeprazoie Magnesium Trihydrate

机译:三水合咪唑类镁的粘膜粘附性颊膜的制备与评价

获取原文
获取原文并翻译 | 示例
       

摘要

The purpose of this study was to develop formulation and systematically evaluate in vitro performances of mucoadhesive patches of Esomeprazoie magnesium trihydrate using HPMC K4M, HPMC (15cps), and HPMC (5cps) for avoiding gastric degradation and prolong the release up to 8 h. The films were smooth and elegant in appearance, uniform in thickness, weight, drug content and good folding endurance. Drug and polymer incompatibility was not shown in FTIR study, in-vitro release studies were reveal that all films exhibited sustained release in range of 87.31 to 98.04% for a period of 8 h. Ex-vivo permeation studies of Esomeprazoie magnesium trihydrate were shown in the range of 84.35 to 91.33%.The best mucoadhesive performance and prolonged release was exhibited by formulation F_2. Formulation F_2 was shown 91.45% drug release after 8 h and 28.4 gm mucoadhesive force. It was followed zero order drug release pattern and non-fickian release behavior. Therefore, buccal patches containing HPMC K4M (3%) was shown satisfactorily results for alternative route of administration of Esomeprazoie magnesium trihydrate for avoiding gastric degradation and sustain release.
机译:这项研究的目的是开发配方并使用HPMC K4M,HPMC(15cps)和HPMC(5cps)避免三水合Esomeprazoie三水合镁的粘膜粘附贴剂的体外性能,以避免胃降解并延长释放长达8小时。这些薄膜外观光滑,优雅,厚度,重量,药物含量均匀并且具有良好的耐折性。 FTIR研究未显示药物和聚合物的不相容性,体外释放研究表明,所有薄膜在8 h内均表现出在87.31%至98.04%范围内的持续释放。 Esomeprazoie三水合镁的离体渗透研究显示在84.35%至91.33%的范围内。制剂F_2表现出最佳的粘膜粘附性能和延长释放。在8小时后,制剂F_2显示出91.45%的药物释放和28.4gm的粘膜粘附力。遵循零级药物释放模式和非菲克安释放行为。因此,令人满意的结果表明,含有HPMC K4M(3%)的颊贴片可以替代Esomeprazoie三水合镁的给药途径,从而避免胃部降解和持续释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号